BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Stem cell
,
Human chorionic gonadotropin
,
Trichostatin A
,
rs2476601
,
LEP
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
immune markers
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Antigen receptor activated splenic B-lymphocytes with and without anti-IgM treatment
B-cell lymphoma SUDHL4 cells stimulated with both megaCD40L and IgM/G
Explore Curated Studies Results
Literature
Most Relevant Literature
Intrafollicular soluble receptor for advanced glycation end products (sRAGE) and embryo quality in a…
Impact of partial sleep deprivation on immune markers.
Mechanisms of immunotherapy and surrogate markers.
Effects of oral hyposensitization therapy with nickel on haemoglobin and haematocrit values in sensi…
Could receptors for advanced glycation end products be considered cardiovascular risk markers in obe…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.
Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Inf…
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatmen…
Determining Prognostic Immune Markers in Patients With Ovarian Cancer
Immune Activation Markers in HIV-infected Patients Switching to Long Acting Dual Therapy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ